Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Flyer

Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 14
  • Journal CiteScore: 3.77
  • Journal Impact Factor: 4.09
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles

Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer

Primary Central Nervous System Lymphoma: A Critical Review of the Role of Surgery for Resection

Google Scholar citation report
Citations : 1140

Archives in Cancer Research received 1140 citations as per Google Scholar report

Flyer image
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • J-Gate
  • Secret Search Engine Labs
  • International Committee of Medical Journal Editors (ICMJE)
  • Zenodo
View More
Share This Page

Brunetti Oronzo

Brunetti Oronzo
Oncologist researcher for clinical/translational projects in HCC and pancreatic cancer patients, Medical Oncology Unit
National Cancer Institute IRCCS "Giovanni Paolo II, Italy

Biography

Oronzo Brunetti graduated cum laude in 2008 from the University of Bari School of Medicine, Bari, Italy. Since graduation, he has become involved in studies on translational research in solid tumors. Since 2014, he is a member of AIOM (the Italian Association of Medical Oncology). Since 2015, he is a member of the Italian Group for Diagnosis and Treatment of Biliary Cancer (GICO). From 2016 he has been involved in the elaboration of guidelines of exocrine pancreatic carcinoma for the AIOM. He has published 20 papers in peer-reviewed journals, most of them on gastrointestinal cancers. He is actually involved a research project for identification of prognostic/predictive biomarkers in pancreatic, biliary, and hepatocellular cancer.